DudeMeds vs Hers: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

DudeMeds beats Hers overall, scoring 7.8/10 vs 7.3/10. DudeMeds is more affordable at $149/mo vs $199/mo. Choose DudeMeds for men who want glp-1 weight loss from a men's health-focused p. Choose Hers for women who want brand-name wegovy (injection or pill) at $149.

A side-by-side comparison of DudeMeds and Hers covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

DudeMeds

#15 of 48

7.8/10

Men's health telehealth platform offering compounded GLP-1 medications tailored to male patients.

Visit DudeMeds

Hers

#35 of 48

7.3/10

The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership — alongside their existing compounded semaglutide and new compounded tirzepatide programs.

Visit Hers

Feature	DudeMeds	Hers
Our Score	7.8/10	7.3/10
Starting Price	$149/mo	$199/mo
Medication Type	Compounded	Both
Insurance Accepted	No	No
Best For	Men who want GLP-1 weight loss from a men's health-focused platform	Women who want brand-name Wegovy (injection or pill) at $149/mo via the 2026 Novo Nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand
Ranking	#15	#35

Pros & Cons Compared

DudeMeds

Pros

+Simplest all-in pricing: $199/mo flat covering medication, consultation, and free shipping — zero hidden fees
+48-hour medication shipping — among the fastest fulfillment times in the industry
+No doctor visit required in most states — maximally convenient for patients who don't want appointments
+Serves both men and women despite the brand name

Cons

−No video or phone consultation in most states — minimal clinical oversight compared to platforms with regular check-ins
−No publicly disclosed headquarters, founding date, or pharmacy partners — lack of transparency
−Limited online review presence makes it difficult to verify patient satisfaction claims

Hers

Pros

+2026 Novo Nordisk partnership — FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
+Zepbound access via the Lilly/Hims-Hers partnership announced 2026
+Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
+Broader women's health platform — integrates weight loss with hormonal, skin, and wellness services

Cons

−Membership + medication are billed separately ($39 first month / $149 ongoing membership) — watch the all-in math
−Generic support experience — large patient volume means less personalized attention
−Compounded pricing starts at $199/mo but stepped pricing applies at higher doses
−Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership — read as access, not value

Our Verdict

DudeMeds edges out Hers with a score of 7.8/10 vs 7.3/10. If budget is your priority, DudeMeds starts at $149/mo compared to Hers's $199/mo. Hers offers both brand-name and compounded medications, giving you more flexibility. Choose DudeMeds if you want: men who want glp-1 weight loss from a men's health-focused platform. Choose Hers if you want: women who want brand-name wegovy (injection or pill) at $149/mo via the 2026 novo nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither DudeMeds nor Hers feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review